Freehills Patent Attorneys announces qualifications for 2 more patent professionals

Date: 2013-02-05

Freehills Patent Attorneys is delighted to announce that Carol Burnton is now a registered patent attorney and Emma Lees has passed all professional examinations required for registration as a patent attorney. This is an excellent outcome for our people and for our clients.




Carol Burnton


Carol is a Patent Attorney in the pharmaceutical and biotechnology team. Carol is highly regarded for complex patent validity, infringement and freedom to operate advice. She has experience in challenging and defending the validity of pharmaceutical patents before the Patent Office and the Federal Court of Australia. Carol also supports her clients with drafting and prosecuting patent applications and providing strategic patenting advice.


Before joining Freehills Patent Attorneys, Carol worked as a Solicitor for Freehills law firm (now Herbert Smith Freehills) gaining experience in intellectual property litigation, contracting and due diligence reviews in preparation for mergers or acquisitions.


Carol joined Freehills law firm in 2008 after completing an honours thesis in biochemistry in the immunology laboratory of the Institute for Molecular Biosciences at the University of Queensland. Her thesis on cellular cytoplasmic responses to double-stranded DNA received the award for the best honours thesis in biochemistry in 2007. Carol’s research resulted in co-authorship of a paper, which was published in the highly ranked, peer-reviewed journal Science in 2009.


Carol’s scientific study, research and work has provided her with experience in organic chemistry, biochemistry, genetics, immunology, cell culture and many visualisation techniques.



Emma Lees


Emma is a Patent Scientist within the chemistry / biotechnology team where she supports clients with drafting and prosecuting Australian and foreign patent applications and providing strategic IP advice.


Prior to joining Freehills in 2010, Emma completed her PhD at the University of Melbourne and the Ludwig Institute for Cancer Research, specialising in nanotechnology and biochemistry. Emma’s PhD studies involved the development of biocompatible semiconductor nanocrystals for use as bio-labels in cancer detection. Emma also has experience, from her honours research, in the synthesis and characterisation of recombinant proteins that form amyloid fibrils within atherosclerotic plaques. In these roles she acquired extensive experience in the fields of nanotechnology, materials chemistry, biochemistry and molecular biology. She has a detailed knowledge of surface chemistry, biocompatibility, addition of biofunctionality, recombinant protein synthesis and the structural characterisation of proteins.


Whilst undertaking the Masters of Intellectual Property Law at the University of Melbourne, Emma was awarded the Frank Pinkerton Scholarship for best result in Designs Law and Practice.


Emma has authored peer reviewed articles and reviews in journals such as ACS Nano, Small and the Journal of Molecular Biology. Articles can be viewed at the US National Library of Medicine, National Institutes of Health, National Center for Biotechnology Information (PubMed).